Inger Brandt
Impact in
-
- Neuropeptides and Animal Physiology
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 10
- Peptidase Inhibition and Analysis 10
-
- Neuropeptides and Animal Physiology 7
- Co-authors
- Anne‐Marie Lambeir (9 shared papers)Ingrid De Meester (8 shared papers)Simon Scharpé (5 shared papers)Simon Scharpé (4 shared papers)Marie-Berthe Maes (4 shared papers)Marc Vanderheyden (2 shared papers)Jean‐Marie Ketelslegers (1 shared paper)Koen Augustyns (5 shared papers)
- Journals
- Clinica Chimica Acta (2 papers)Peptides (2 papers)Clinical Chemistry (1 paper)Advances in experimental medicine and biology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- BelgiumTaiwanNetherlands
In The Last Decade
Inger Brandt
16 papers receiving 667 citations
Peers
Comparison fields: 5 of 84
- Cellular and Molecular Neuroscience 281
- Oncology 421
- Endocrinology, Diabetes and Metabolism 226
- Physiology 22
- Cardiology and Cardiovascular Medicine 101
Countries citing papers authored by Inger Brandt
This map shows the geographic impact of Inger Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Brandt more than expected).
Fields of papers citing papers by Inger Brandt
This network shows the impact of papers produced by Inger Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Brandt. The network helps show where Inger Brandt may publish in the future.
Co-authors
The 25 scholars most cited alongside Inger Brandt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 159 | |
| 2 | 2005 | 106 | |
| 3 | 2008 | 76 | |
| 4 | 2006 | 75 | |
| 5 | 2007 | 56 | |
| 6 | 2007 | 44 | |
| 7 | 2005 | 32 | |
| 8 | 2008 | 29 | |
| 9 | 2006 | 25 | |
| 10 | 2008 | 25 | |
| 11 | 2011 | 24 | |
| 12 | 2015 | 16 | |
| 13 | 2019 | 10 | |
| 14 | 2016 | 5 | |
| 15 | 1954 | 4 | |
| 16 | 2019 | 3 |
About Inger Brandt
Inger Brandt is a scholar working on Oncology, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research, having authored 16 papers that have together received 689 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers), Diabetes Treatment and Management (3 papers), Protease and Inhibitor Mechanisms (3 papers), Signaling Pathways in Disease (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (281 citations), Oncology (421 citations), Endocrinology, Diabetes and Metabolism (226 citations), Physiology (22 citations) and Cardiology and Cardiovascular Medicine (101 citations). Inger Brandt has collaborated with scholars based in Belgium, Taiwan and Netherlands. Frequent co-authors include Anne‐Marie Lambeir, Ingrid De Meester, Simon Scharpé, Simon Scharpé, Marie-Berthe Maes, Marc Vanderheyden, Jean‐Marie Ketelslegers, Koen Augustyns, Xin Chen and Jurgen Joossens. Their work appears in journals such as Clinica Chimica Acta, Peptides, Clinical Chemistry, Advances in experimental medicine and biology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.